Updated indications for the recombinant, adjuvanted RSV vaccine

Description

In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.

This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.
PM-AU-RSA-WCNT-250023. Date of approval: May 2025.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Ted Wu

Dr Ted Wu

Cardiovascular Outcomes & GLP1 – An Update

Dr Alison Chiu

Dr Alison Chiu

Dry Eye – Practical Management Tips for Better Outcome

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Andrew Sindone

expert

Prof Andrew Sindone

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital

Date published: 27 May 2025